
Fc-engineered CD9 antibodies for blood cancers
The invention
- Name of invention
- Fc-engineered CD9 antibodies for blood cancers
- Anticorps CD9 modifiés Fc pour les cancers du sang
Invention description
- Description
- New prototypes of therapeutic CD9 antibody are generated by Fc engineering with potent activities against refractory leukemia and excellent safety profiles. Toxicity of CD9 antibodies, a longstanding hurdle for clinical translation, is resolved.
INVENTORS
The Chinese University of Hong Kong / Prof. Kam Tong LEUNG inventor 3700782898_3031
Information in this online catalogue is based on data received for the Event and updated by the participant. Catalogue entries remain the sole responsability of the participant. The Exhibition management declines all responsibility for any possible errors or omissions.